Reuters
People who carry two copies of the APOE4 gene are virtually guaranteed to develop Alzheimer's and face symptoms at an earlier age, researchers reported on Monday in a study that could redefine such carriers as having a new genetic form of the mind-wasting disease. The reclassification could change Alzheimer's research, diagnosis and approaches to treatment, according to the researchers, whose study was published in the journal Nature Medicine. "Through these data we are saying that perhaps this is a genetic form of this disease, not merely a risk factor indication," study co-author Sterling Johnson of the University of Wisconsin's Alzheimer's Disease Research Center told reporters in a briefing on the study.